RBC Capital Lowers PT on Clarivate Plc (CLVT) Following Q4 2025 Results

​Clarivate Plc (NYSE:CLVT) is one of the Best Value Penny Stocks to Buy Now. On February 24, Clarivate Plc (NYSE:CLVT) released its fiscal Q4 2025 earnings. Following the release, RBC Capital lowered the firm’s price target on the stock from $5 to $3 and maintained a Sector-Perform rating.

​The company posted $617 million in revenue, reflecting 6.94% year-over-year decline and missed estimates by $12.21 million. However, the EPS of $0.20 topped estimates by $0.04. Management attributed the decline in revenue to the ongoing divestitures and disposals. Moreover, the organic subscription growth of 1% was offset by lower organic recurring and transactional revenues. Despite this, the net income for the quarter turned positive from a net loss of $191.8 million a year ago to $3.1 million.

​RBC Capital noted that the company delivered solid free cash flow growth and also guided to 10% growth for fiscal 2026. However, the firm believes that the concerns regarding the ongoing AI risks and execution in the life sciences and healthcare segment led to a lower price target.

​Clarivate Plc (NYSE:CLVT) is a leading global provider of transformative intelligence, offering subscription-based data, analytics, and software to help organizations accelerate innovation. It serves academic, government, legal, and life sciences sectors, managing intellectual property (IP), scientific research, and pharmaceutical intelligence.​

While we acknowledge the potential of CLVT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. Follow Insider Monkey on Google News.